Welcome to the real world Matthew Gordon examines the differences between observational studies and phase III clinical trials(more)
Drug regulation: still room for improvement The Medicines Act is 40 years old this year, but regulations and regulators have to change to keep up with rapid changes in medicines and society, says Les Rose.(more)
Connecting with patients Tuesday , February 08, 2005
Using the internet to make patients aware of clinical trials remains a relatively new idea, but it could increase participation and halt expensive delays to a drug's launch....(more)
Open up to expert patients Tuesday , February 01, 2005
What role does the pharmaceutical industry have to play in the expert patient initiative and can the government's planned national roll-out be achieved by 2007?...(more)
NHS Trust - can pharma win it? Tuesday , February 01, 2005
To win over a sceptical medical community pharma companies need to be open and ethical when developing healthcare partnerships with an overburdened NHS. ...(more)
Changing the headlines Tuesday , February 01, 2005
The public may have a negative perception of the pharma industry, but by taking a proactive stance the industry can highlight the positive role it plays in society. ...(more)
